Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Ordinary shares
-
Shares outstanding
-
49,942,911
-
Total 13F shares
-
35,286,231
-
Share change
-
+2,620,985
-
Total reported value
-
$2,114,539,636
-
Put/Call ratio
-
18%
-
Price per share
-
$59.96
-
Number of holders
-
116
-
Value change
-
+$164,445,131
-
Number of buys
-
75
-
Number of sells
-
40
Institutional Holders of Immunocore Holdings plc - Ordinary shares (IMCR) as of Q2 2023
As of 30 Jun 2023,
Immunocore Holdings plc - Ordinary shares (IMCR) was held by
116 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,286,231 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP, Rock Springs Capital Management LP, BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, Paradigm Biocapital Advisors LP, GENERAL ATLANTIC, L.P., PICTET ASSET MANAGEMENT SA, and MORGAN STANLEY.
This page lists
118
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.